From 5 November 2026 the Poisons and Therapeutic Goods Act and Regulation will be replaced by the:
The new Act and the Regulation support safe, modern healthcare practices and business operations. These laws set clear rules to control the supply of scheduled substances and therapeutic goods in NSW, with the primary goal of protecting public health and safety.
This factsheet outlines key legislative changes relevant to dentists and dental practitioners.
This is an increase from the previous period of 6 months. Schedule 4D medicines include those that are anabolic-androgenic steroidal medicines.
Dentists can only issue a prescription supply, or administer a Schedule 8 medicine that is listed in the Dental Schedule of the Pharmaceutical Benefits Scheme, unless the medicine is for a patient in a public health entity or private health facility.
Dentists cannot self-prescribe Schedule 8 and Schedule 4D medicines or obtain them via wholesale for self-administration.
Dentists must now report only unexplained losses of these medicines to Pharmaceutical Services. However, all losses of Schedule 8 medicines must be recorded in the drug register.
Note: explained losses include residual volume left in the syringe or needle hub, a witnessed and unrecoverable spill etc.
[back to top]
Dentists can only prescribe or supply a scheduled medicine to a patient for a total period of up to one month of continuous therapeutic use. This one-month period includes any previous prescriptions or supplies of the medicine provided by the dentist in previous visits.
Note: under previous legislation this only applied when prescribing a scheduled medicine.
Dentists must now record the balance of Schedule 8 medicine in a drug register at least once every 3 months.
For private and public hospitals, the stocktake requirement remains 6-monthly and may be conducted in any month (it is no longer limited to March and September).
In private practice an authorised practitioner is responsible for keeping a compliant drug register on the practice premises where Schedule 8 medicines are kept. Please ensure you are aware of any obligations you may have.
From 5 November, all health practitioners must comply with following:
Dentists can only request to obtain registered Schedule 4 and 8 medicines for emergency or urgent use from a pharmacy. Unregistered products are no longer permitted to be supplied as urgent use medicines.
The registered medicine isn’t restricted to those listed on the PBS Prescriber Bag orders.
Dentists must provide a written and signed order for the pharmacist to supply the registered medicine. A record of the request for this supply must be kept for two years.
If a dentist needs medicines for non-urgent use, you can continue to obtain these from a wholesaler.
Dental therapists, oral health therapists and dental hygienists can:
Dental therapists and oral health therapists can obtain supplies tetracycline and triamcinolone for use in preparation for the treatment of dental pulp.
Prescriptions issued by dentists are no longer required to be endorsed with the words “For Dental Treatment Only”. Dentists must still exercise their clinical judgment and only prescribe within their scope of practice.
Samples of Schedule 4D and Schedule 8 medicines are no longer permitted. Dentists must issue a written order when receiving samples for other scheduled medicines.
Dentists working in public health entities must continue to comply with the NSW Ministry of Health Policy Directive on Medicines Handling.
Dentists working in private health facilities and managed correctional centres must comply with the facility or centre’s medicines policies and procedures.
The labelling of scheduled substances is no longer listed in the Regulation. Scheduled substances must be labelled as per the requirements of the Poisons Standard.
Repeats can be given back to the patient to be dispensed at their pharmacy of choice.
Handwritten prescriptions must be legible for the prescription to be valid.
Dentists no longer need to underline high or unusual doses on a prescription.
To help reduce harms associated with the misuse of nitrous oxide, new restrictions will apply to its supply for non-therapeutic purposes. These measures are intended to support the safe and responsible supply of nitrous oxide and limit access where there is a risk of misuse.
More information is available at Nitrous Oxide Regulations.
The Act and Regulation set out penalties for offences associated with unauthorised activities.
Penalties are classified in 5 tiers and differ for individuals and corporations. They range from 20 to 400 penalty units for individuals and 100 to 2000 penalty units for corporations.
More information can be found in the offences and penalties section of the Act and the Regulation. Further information on compliance notices and penalties will also be available at a later date.
Further definitions and terminology can be found at key definitions and terminology.
[back to top]
Supporting information to help understand the requirements of the legislation is available on the Medicines, Poisons and Therapeutic Goods legislation webpage.
The information on this webpage is provided for general guidance only. While reasonable care has been taken to ensure the accuracy, reliability, and currency of the information, users should refer to the Medicines, Poisons and Therapeutic Goods Act 2022 and the Medicines, Poisons and Therapeutic Goods Regulation 2026 for full legal requirements.